Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma

Publication date: May 2016
Source:European Journal of Cancer, Volume 59
Author(s): Alexander Roesch, Annette Paschen, Jenny Landsberg, Iris Helfrich, Jürgen C. Becker, Dirk Schadendorf
Despite the recent success of MAPK and immune checkpoint inhibitors in advanced melanoma, intrinsic and acquired resistance mechanisms determine the efficacy of these therapeutic approaches. Therapy resistance in melanoma is not solely driven by genetic evolution, but also by epigenetically driven adaptive plasticity. Melanoma cells are shifting between different transcriptional programs, cell cycle states and differentiation phenotypes reflecting a highly dynamic potential to adapt to various exogenous stressors including immune attack or cancer therapies. This review will focus on the dynamic interconversion and overlap between different melanoma cell phenotypes in the context of therapy resistance and a dynamically changing multicellular microenvironment.



from Cancer via ola Kala on Inoreader http://ift.tt/22RtDmH
via IFTTT